# Allurion Technologies, Inc.: filings

ALUR · OTC · CIK 1964979 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/alur.md) · [Financials](/companies/alur/financials.md) · [Filings](/companies/alur/filings.md) · [Insiders](/companies/alur/insiders.md)

## Reports and events: 104 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (424B3 77, 8-K 55, 4 21, 3 15, CORRESP 15, EFFECT 12, UPLOAD 12, SCHEDULE 13D/A 10, 10-Q 9, 425 7, S-1/A 7, S-4/A 6, S-1 5, 10-Q/A 4, POS AM 4, 10-K 3, 10-K/A 3, 424B5 3, D 3, DEF 14A 3, NT 10-Q 3, PRE 14A 3, S-3 3, SC 13D/A 3, SC 13G/A 3, 4/A 2, 5 2, ARS 2, DEFA14A 2, DRS 2, S-8 2, SC 13G 2, SCHEDULE 13G/A 2, 144 1, 25-NSE 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, DRSLTR 1, PRER14A 1, RW 1, S-3/A 1, S-4 1, SC 13D 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-02 | 00:03 ET | [SCHEDULE 13D/A](/filings/0001493215-26-000166.md) | Ownership report, active investor, amended | 0001493215-26-000166 |
| 2026-08-24 | 21:30 ET | [8-K](/filings/0001193125-26-363811.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-363811 |
| 2026-07-24 | 20:50 ET | [8-K](/filings/0001193125-26-316202.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-316202 |
| 2026-07-23 | 21:19 ET | [SCHEDULE 13D/A](/filings/0001493215-26-000135.md) | Ownership report, active investor, amended | 0001493215-26-000135 |
| 2026-07-23 | 21:00 ET | [8-K](/filings/0001193125-26-314263.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-314263 |
| 2026-07-07 | 12:05 ET | [8-K](/filings/0001193125-26-296918.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-296918 |
| 2026-06-30 | 21:00 ET | [8-K](/filings/0001193125-26-290772.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-290772 |
| 2026-06-17 | 20:35 ET | [8-K](/filings/0001193125-26-274250.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-274250 |
| 2026-05-27 | 20:35 ET | [8-K](/filings/0001193125-26-242009.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-26-242009 |
| 2026-05-15 | 20:30 ET | [10-Q](/filings/0001193125-26-226960.md) | Quarterly report, period 2026-03-31 | 0001193125-26-226960 |
| 2026-03-30 | 12:30 ET | [10-K](/filings/0001193125-26-130483.md) | Annual report, period 2025-12-31 | 0001193125-26-130483 |
| 2026-03-12 | 21:11 ET | [8-K](/filings/0001193125-26-104434.md) | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-104434 |
| 2026-03-02 | 21:20 ET | [SCHEDULE 13D/A](/filings/0001493215-26-000066.md) | Ownership report, active investor, amended | 0001493215-26-000066 |
| 2026-03-02 | 14:18 ET | [8-K](/filings/0001193125-26-084412.md) | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-084412 |
| 2026-02-25 | 13:30 ET | [8-K](/filings/0001193125-26-068667.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-26-068667 |
| 2026-02-23 | 14:06 ET | [8-K](/filings/0001193125-26-062599.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-062599 |
| 2026-01-12 | 21:30 ET | [8-K](/filings/0001193125-26-010462.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-010462 |
| 2025-12-19 | 22:00 ET | [8-K](/filings/0001193125-25-327032.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-327032 |
| 2025-11-24 | 21:05 ET | [DEF 14A](/filings/0001193125-25-293675.md) | Proxy statement, period 2025-12-18 | 0001193125-25-293675 |
| 2025-11-17 | 21:14 ET | [10-Q](/filings/0001193125-25-284630.md) | Quarterly report, period 2025-09-30 | 0001193125-25-284630 |
| 2025-11-13 | 22:20 ET | [SCHEDULE 13D/A](/filings/0001493215-25-000030.md) | Ownership report, active investor, amended | 0001493215-25-000030 |
| 2025-11-12 | 13:15 ET | [8-K](/filings/0001193125-25-276066.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-276066 |
| 2025-11-07 | 22:21 ET | [SCHEDULE 13D/A](/filings/0001493215-25-000016.md) | Ownership report, active investor, amended | 0001493215-25-000016 |
| 2025-10-03 | 20:30 ET | [8-K](/filings/0001193125-25-230301.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-230301 |
| 2025-08-28 | 20:42 ET | [10-Q/A](/filings/0000950170-25-112011.md) | Quarterly report, amended, period 2024-09-30 | 0000950170-25-112011 |
| 2025-08-28 | 20:38 ET | [10-Q/A](/filings/0000950170-25-112000.md) | Quarterly report, amended, period 2024-06-30 | 0000950170-25-112000 |
| 2025-08-28 | 20:34 ET | [10-Q/A](/filings/0000950170-25-111984.md) | Quarterly report, amended, period 2024-03-31 | 0000950170-25-111984 |
| 2025-08-28 | 20:30 ET | [10-K/A](/filings/0000950170-25-111978.md) | Annual report, amended, period 2023-12-31 | 0000950170-25-111978 |
| 2025-08-19 | 21:18 ET | [10-Q](/filings/0000950170-25-110188.md) | Quarterly report, period 2025-06-30 | 0000950170-25-110188 |
| 2025-08-19 | 20:53 ET | [10-Q/A](/filings/0000950170-25-110164.md) | Quarterly report, amended, period 2025-03-31 | 0000950170-25-110164 |
| 2025-08-19 | 20:30 ET | [10-K/A](/filings/0000950170-25-110133.md) | Annual report, amended, period 2024-12-31 | 0000950170-25-110133 |
| 2025-08-14 | 21:22 ET | [8-K](/filings/0001193125-25-180926.md) | 4.02 Non-reliance on financial statements | 0001193125-25-180926 |
| 2025-08-13 | 12:15 ET | [8-K](/filings/0000950170-25-107634.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-107634 |
| 2025-08-07 | 22:44 ET | [8-K](/filings/0000950170-25-104347.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-104347 |
| 2025-05-15 | 20:15 ET | [10-Q](/filings/0000950170-25-072662.md) | Quarterly report, period 2025-03-31 | 0000950170-25-072662 |
| 2025-05-14 | 12:15 ET | [8-K](/filings/0000950170-25-070934.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-070934 |
| 2025-04-17 | 22:34 ET | [SCHEDULE 13D/A](/filings/0000950170-25-055659.md) | Ownership report, active investor, amended | 0000950170-25-055659 |
| 2025-04-17 | 20:15 ET | [8-K](/filings/0000950170-25-055398.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-25-055398 |
| 2025-04-10 | 21:07 ET | [8-K](/filings/0000950170-25-052927.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-052927 |
| 2025-04-03 | 21:19 ET | [8-K](/filings/0001193125-25-072475.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-072475 |
| 2025-03-27 | 20:08 ET | [10-K](/filings/0000950170-25-046063.md) | Annual report, period 2024-12-31 | 0000950170-25-046063 |
| 2025-03-26 | 12:15 ET | [8-K](/filings/0000950170-25-044805.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-044805 |
| 2025-03-24 | 10:09 ET | [DEF 14A](/filings/0001193125-25-060793.md) | Proxy statement, period 2025-04-04 | 0001193125-25-060793 |
| 2025-02-24 | 21:15 ET | [SCHEDULE 13D/A](/filings/0000950170-25-025629.md) | Ownership report, active investor, amended | 0000950170-25-025629 |
| 2025-02-21 | 21:06 ET | [8-K](/filings/0001193125-25-031990.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-031990 |
| 2025-02-13 | 22:13 ET | [8-K](/filings/0001193125-25-026187.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-026187 |
| 2025-01-29 | 21:10 ET | [SCHEDULE 13D/A](/filings/0000950170-25-010486.md) | Ownership report, active investor, amended | 0000950170-25-010486 |
| 2025-01-28 | 02:57 ET | [8-K](/filings/0001193125-25-013703.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-013703 |
| 2025-01-16 | 01:22 ET | [SCHEDULE 13D/A](/filings/0000950170-25-006412.md) | Ownership report, active investor, amended | 0000950170-25-006412 |
| 2025-01-17 | 00:24 ET | [8-K](/filings/0001193125-25-007863.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-007863 |

Page 1 of 3. [Older](/companies/alur/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.